Paul T Nghiem

41PUBLICATIONS
159CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyPredictive and prognostic markersGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (41)

|Sep 09, 2026
Reprogramming engineered autologous T cells to overcome resistance in patients with Merkel cell carcinoma.

|Aug 27, 2026
Minimal Efficacy of Single-Agent Anti-PD-(L)1 Re-Exposure in Anti-PD-(L)1-Refractory Merkel Cell Carcinoma: A Retrospective Cohort Study of 16 Patients.

|Apr 29, 2026
Immunotherapy Significantly Improves Merkel Cell Carcinoma-Specific Survival: A Single-Cohort Propensity Score-Matched Analysis.

|Mar 04, 2026
Response of B Cells Specific for Polyomavirus-Derived Oncoprotein Is Predictive of Merkel Cell Carcinoma Tumor Control.

Haroldo J Rodriguez Chevez, Allison J Remington, Matthew D Gray

|Dec 25, 2025
Real-world outcomes of talimogene laherparepvec as salvage therapy for advanced melanoma.

Melissa M Yamada, Smitha Chandrasekhar, Ted A Gooley

|Oct 23, 2025
Circulating Neoantigen- and Viral Oncoprotein-Specific CD8+ T Cells Share a Transcriptional Signature.

Saumya Jani, Tomas Bencomo, Carolyn Shasha

Pageof 7

Frequent Collaborators

12 joint publications

Shailender Bhatia

10 joint publications

Tomoko Akaike

9 joint publications

David M Koelle

8 joint publications

Candice D Church